Daiichi Sankyo
Mohammad Farooq possesses extensive experience in clinical research and academia, currently serving as a Clinical Study Manager at Daiichi Sankyo, Inc. and previously held the position of Senior Clinical Study Associate. Additional roles include Clinical Study Manager at Zentalis Pharmaceuticals and Associate Director of Clinical Research at Crohn's & Colitis Foundation. Mohammad also contributes to education as an Adjunct Professor at Hunter College and offers consultancy services through the South Asian Mental Health Initiative and Network. Academically, Mohammad holds a Master of Public Health (M.P.H.) in Epidemiology and a Master's in Biomedical Sciences with a focus on Pharmacology, both obtained from Rutgers University between 2012 and 2017.
This person is not in the org chart
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.